Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Bibliographic Details
Main Authors:	Inzucchi, SE, Bergenstal, R, Buse, J, Diamant, M, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D
Format:	Journal article
Published:	2012

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
by: Inzucchi, SE, et al.
Published: (2012)

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
by: Inzucchi, SE, et al.
Published: (2012)

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
by: Inzucchi, SE, et al.
Published: (2012)

Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
by: Inzucchi, SE, et al.
Published: (2012)

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (vol 55, pg 1577, 2012)
by: Inzucchi, SE, et al.
Published: (2013)

Response to comments on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35: 1364-1379
by: Matthews, DR, et al.
Published: (2012)

ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]
by: Matthews, DR, et al.
Published: (2012)

ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter].
by: Matthews, DR, et al.
Published: (2012)

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
by: Nathan, D, et al.
Published: (2009)

Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
by: Nathan, D, et al.
Published: (2009)

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
by: Nathan, D, et al.
Published: (2008)

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
by: Nathan, D, et al.
Published: (2006)

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
by: Nathan, D, et al.
Published: (2009)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC
by: Zachary Bloomgarden, et al.
Published: (2020-03-01)

Comments on the Consensus statement of the American Diabetes Association and the European Association for the Studyof Diabetes on the medical management of hyperglycemia in type 2 diabetes
by: Ivan Ivanovich Dedov, et al.
Published: (2009-06-01)

The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
by: Aschner Pablo J
Published: (2010-12-01)

COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007
by: M. V. Shestakova
Published: (2015-12-01)

ESC GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES DEVELOPED IN COLLABORATION WITH THE EASD
by: Lars Rydén, et al.
Published: (2014-03-01)

COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007
by: M. V. Shestakova
Published: (2015-12-01)

Annual Congress of European Association for the Study of Diabetes (EASD), 29 September - 2 October 2009, Vienna.Session: Diabetes and pragnancy
by: Lyubov' Leonidovna Bolotskaya, et al.
Published: (2009-12-01)

Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy
by: Nathan, D, et al.
Published: (2009)

Guidelines on diabetes, pre-diabetes and cardiovascular diseases. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), 2007
by: Editorial team Diabetes Mellitus
Published: (2008-03-01)

46rd Congress of European Association for the Study of Diabetes (EASD), 20-24 September 2010, Stokholm
by: Inna Igorevna Klefortova
Published: (2010-09-01)

The 47th Annual meeting of the European Association for the Study of Diabetes (EASD), 12-16 September, Lisbon
by: Anatoliy Gennad'evich Kuz'min, et al.
Published: (2011-09-01)

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
by: Nathan, D, et al.
Published: (2006)

The American Diabetes Association’s (ADA’s) standards of medical care in diabetes (2018): diagnostics and treatment of diabetes mellitus
by: В. І. Паньків
Published: (2018-04-01)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
by: Angermann Christiane E, et al.
Published: (2011-02-01)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
by: Adler, A, et al.
Published: (1999)

Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes
by: Paul Valensi, et al.
Published: (2023-02-01)

A case of mody 2 - Associated hyperglycemia diagnosed as gestational diabetes
by: Chakarova N., et al.
Published: (2023-03-01)

PREVALENCE OF DIABETIC-RETINOPATHY AT DIAGNOSIS OF NON-INSULIN-DEPENDENT DIABETES IN 2964 WHITE CAUCASIAN SUBJECTS AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION
by: Stratton, I, et al.
Published: (1995)

N of 1 trials in diabetes: making individual therapeutic decisions.
by: Tsapas, A, et al.
Published: (2008)

Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
by: Minh Dao Ngo, et al.
Published: (2021-11-01)

A comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure guideline and the 2017 American Diabetes Association Diabetes and Hypertension position statement for U.S. adults with diabetes
by: Muntner, P, et al.
Published: (2018)

Assessment of Achievement of American Diabetes Association (ADA) Targets in Patients with Type 2 Diabetes Mellitus at a Tertiary Care Centre in Eastern Nepal
by: Baranwal JK, et al.
Published: (2020-08-01)

Association between hyperglycemia and adverse clinical outcomes of sepsis patients with diabetes
by: Shan Lin, et al.
Published: (2023-01-01)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
by: Ivona Renata Yarek-Martynova, et al.
Published: (2011-12-01)

Diabetic bladder dysfunction is associated with bladder inflammation triggered through hyperglycemia, not polyuria
by: Inouye BM, et al.
Published: (2018-11-01)

A comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure guideline and the 2017 American Diabetes Association Diabetes and Hypertension position statement for U.S. adults with diabetes
by: Muntner, P, et al.
Published: (2018)

Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes.
by: Matthews, DR, et al.
Published: (2008)

Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Similar Items

Similar Items